Efficacy of Pirtobrutinib in Covalent BTK-Inhibitor Pre-Treated Relapsed / Refractory Mantle Cell Lymphoma: Additional Patients and Extended Follow-up from the Phase 1/2 BRUIN Study

Wang, M. L., Shah, N. N., Jurczak, W., Zinzani, P. L., Eyre, T. A., Cheah, C. Y., Ujjani, C. S., Koh, Y., Izutsu, K., Gerson, J. N., Flinn, I. W., Tessoulin, B., Alencar, A. J., Ma, S., Lech-Marańda, E., Rhodes, J. M., Patel, K., Woyach, J. A., Lamanna, N., … Mato, A. R. (2022). Efficacy of Pirtobrutinib in Covalent BTK-Inhibitor Pre-Treated Relapsed / Refractory Mantle Cell Lymphoma: Additional Patients and Extended Follow-up from the Phase 1/2 BRUIN Study. Blood, 140(Supplement 1), 9368–9372. https://doi.org/10.1182/blood-2022-159425
Authors:
Michael Wang
Nirav N. Shah
Wojciech Jurczak
Pier Luigi Zinzani
Toby A. Eyre
Chan Y. Cheah
Chaitra S. Ujjani
Youngil Koh
Koji Izutsu
James N. Gerson
Ian W. Flinn
Benoît Tessoulin
Alvaro J. Alencar
Shuo Ma
Ewa Lech‐Marańda
Joanna Rhodes
Krish Patel
Jennifer A. Woyach
Nicole Lamanna
Yucai Wang
Constantine S. Tam
John F. Seymour
Talha Munir
Hirokazu Nagai
Francisco J. Hernandez‐Ilizaliturri
Anita J. Kumar
Andrew D. Zelenetz
Preetesh Jain
Binoj C. Nair
Donald E. Tsai
Minna Balbas
Richard A. Walgren
Paolo Abada
Chunxiao Wang
Junjie Zhao
Anthony R. Mato
Affiliated Authors:
Nicole Lamanna
Columbia Affiliation:
Subjects:
Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia (OpenAlex Topic)
Lymphoid Neoplasms (OpenAlex Topic)
Viral-Related Cancers in Immunocompromised Patients (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1182/blood-2022-159425
DOI:
10.1182/blood-2022-159425
Journal:
Blood
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: